肺动脉压远程监测指导慢性心衰治疗可减少心衰住院:三项随机对照试验的荟萃分析
该荟萃分析纳入三项随机对照试验共1898例NYHA II-IV级门诊心衰患者,评估肺动脉压远程监测指导治疗的效果。
要点
- 全因死亡风险未显著降低(HR 0.92,95%CI 0.73-1.16)。
核心结论
- 使用肺动脉压远程监测指导心衰患者治疗可减少心衰恶化发作及后续住院。
研究设计与样本
- 系统检索随机临床试验后纳入三项符合条件的随机对照试验,共1898例NYHA II-IV级门诊心衰患者(既往12个月内因心衰住院或血浆NT-proBNP升高),平均随访14.7个月。
主要发现
- 全因死亡的风险比为0.92(0.73-1.16)。
- 亚组分析(包括射血分数表型)未显示治疗效果存在异质性。
临床怎么用
- 对于符合试验入组特征的慢性心衰门诊患者,可考虑采用肺动脉压远程监测指导治疗以降低心衰住院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Adjustment of treatment based on remote monitoring of pulmonary artery (PA) pressure may reduce the risk of hospital admission for heart failure (HF). We have conducted a meta-analysis of large randomized trials investigating this question. METHODS AND RESULTS: A systematic literature search was performed for randomized clinical trials with PA pressure monitoring devices in patients with HF. The primary outcome of interest was the total number of HF hospitalizations. Other outcomes assessed were urgent visits leading to treatment with intravenous diuretics, all-cause mortality, and composites. Treatment effects are expressed as hazard ratios, and pooled effect estimates were obtained applying random effects meta-analyses. Three eligible randomized clinical trials were identified that included 1898 outpatients in New York Heart Association functional classes II-IV, either hospitalized for HF in the prior 12 months or with elevated plasma NT-proBNP concentrations. The mean follow-up was 14.7 months, 67.8% of the patients were men, and 65.8% had an ejection fraction ≤40%. Compared to patients in the control group, the hazard ratio (95% confidence interval) for total HF hospitalizations in those randomized to PA pressure monitoring was 0.70 (0.58-0.86) (P = .0005). The corresponding hazard ratio for the composite of total HF hospitalizations, urgent visits and all-cause mortality was 0.75 (0.61-0.91; P = .0037) and for all-cause mortality 0.92 (0.73-1.16). Subgroup analyses, including ejection fraction phenotype, revealed no evidence of heterogeneity in the treatment effect. CONCLUSION: The use of remote PA pressure monitoring to guide treatment of patients with HF reduces episodes of worsening HF and subsequent hospitalizations.
引用
- Clephas PRD, Radhoe SP, Boersma E, et al. Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials. Eur Heart J. 2023. PMID: 37210750. doi:10.1093/eurheartj/ehad346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。